BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Biotech Beach

  Sixgill Provides Blockchain-Enabled Data Integrity for Litmus Health Clinical Trial Analytics and Data Streams

  Sixgill, LLC, the leader in sensor data services for governing Internet of Everything (IoE) assets, today announced Litmus Health will adopt Sixgill Integrity to provide blockchain data accuracy and consistency for its clinical data science platform.

  December 4, 2018

   · 

  4 min read
• Business

  ChemomAb Appoints Dr. Stephen Squinto as Chairman of the Board

  ChemomAb today announced the appointment of Dr. Stephen Squinto as the company’s chairman of the board.

  December 4, 2018

   · 

  2 min read
• Drug Development

  BioTime Announces Publication of Positive Preclinical Results Utilizing Proprietary HyStem® Platform in Ischemic Stroke

  BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced the publication of positive preclinical results which demonstrate that targeted intracerebral delivery of brain-derived neurotrophic factor utilizing HyStem

  December 4, 2018

   · 

  6 min read
• Biotech Bay

  Revance Announces China Market License Agreement with Fosun Pharma for RT002

  Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today announced that the company has entered into a license agreement with Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd

  December 4, 2018

   · 

  8 min read
• Drug Development

  Revance’s RT002 Demonstrates Unprecedented Efficacy and Duration In Largest-Ever Aesthetic Neuromodulator Clinical Program

  In SAKURA 3, RT002 was well-tolerated across over 3,800 treatments in glabellar (frown) lines

  December 4, 2018

   · 

  15 min read
• Business

  ForeverGreen Worldwide Corp. Reports Positive Cash Flow and Lower Overhead Costs Leading the way to Profitability

  The company’s cost structure and effective cash-flow management contribute to overall financial performance

  December 4, 2018

   · 

  2 min read
• Chemistree Provides Washington State Operations Update

  Chemistree Technology Inc. is pleased to announce the following significant developments as provided by its licensee partner managing the cultivation, processing and delivery to points of sale of the Sugarleaf branded suite of products.

  December 4, 2018

   · 

  7 min read
• Biotech Bay

  New DDN Storage-Powered Technology Platform Delivers Researchers Capability for Real-Time Analysis of High-Rate Microscopy Data

  New Solution Delivers 1,600-fold Yield Compared with Traditional Microscopy Workflows

  December 4, 2018

   · 

  4 min read
• Business

  Medidata Rave Omics Collaboration Uncovers Novel Insights for Rare Disease Research

  Discovery of biomarker evidence in Castleman Disease exemplifies the value of personalized medicine in rare diseases

  December 4, 2018

   · 

  4 min read
• Business

  Generex Posts Slides, Script & Recording of the December 3, 2018 Investor Conference Call

  Slide Deck and transcript available for download

  December 4, 2018

   · 

  3 min read